Curis Inc. diskutieren
Curis Inc.
WKN: A2JMX7 / Symbol: CRIS / Name: Curis / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
0,36 €
-8,09 %
Curis, Inc. (NASDAQ: CRIS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $3.00 price target on the stock.
Ratings data for CRIS provided by MarketBeat
Curis, Inc. (NASDAQ: CRIS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Ratings data for CRIS provided by MarketBeat
Curis, Inc. (NASDAQ: CRIS) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $26.00 price target on the stock.
Ratings data for CRIS provided by MarketBeat
Curis, Inc. (NASDAQ: CRIS) had its price target lowered by analysts at HC Wainwright from $51.00 to $26.00. They now have a "buy" rating on the stock.
Ratings data for CRIS provided by MarketBeat
Curis, Inc. (NASDAQ: CRIS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $26.00 price target on the stock.
Ratings data for CRIS provided by MarketBeat
Curis, Inc. (NASDAQ: CRIS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for CRIS provided by MarketBeat
Curis, Inc. (NASDAQ: CRIS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $26.00 price target on the stock.
Ratings data for CRIS provided by MarketBeat
Curis, Inc. (NASDAQ: CRIS) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $26.00 price target on the stock.
Ratings data for CRIS provided by MarketBeat
Curis, Inc. (NASDAQ: CRIS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $26.00 price target on the stock.
Ratings data for CRIS provided by MarketBeat
Neueste Beiträge
StockNews_com in Express Inc. diskutieren